Results 81 to 90 of about 4,258 (204)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K., Anderson, J., Andrews, S., Arrindell, D., Ballesteros, J., Bingham, C. O., Boyer, J., Brogdon, C., Chen, D., Chonzi, D., Cotarla, I., Cunha, R., Dadu, R., Davies, M., Dawson, M., Diab, A., Dicker, Adam, Eifler, L., Ernstoff, M. S., Ferguson, A., Ferlini, C., Frankel, S., Go, W., Gochett, C., Goldberg, J., Goncalves, P., Goswami, T., Gregory, N., Gulley, J. L., Hamad, L., Hayreh, V., Helie, N., Holmes, W., Hsu, J. Y., Ibrahim, R., Kaufman, H. L., Kim, S., Lacouture, M. E., Lambotte, O., Larocca, C., LeBoeuf, N. R., Lehman, K., Lenihan, D., Ley-Acosta, S., Luke, J., McClure, J., Michelon, E., Nakamura, M., Onofrei, C., Patel, K., Piperdi, B., Puzanov, I., Rasheed, Z., Reshef, D., Riemer, J., Robert, C., Sarkeshik, M., Saylors, A., Schreiber, J., Shafer-Weaver, K., Shannon, V., Sharfman, W., Sharma, R., Sharon, E., Sherry, R., Silk, A. W., Simonson, C., Skondra, D., Suarez-Almazor, M. E., Thomas, C., Thompson, J. A., Trehu, E., Tresnan, D., Turner, M., Wang, Y., Wariabharaj, D., Waxman, I., Wiley, K., Wood, L., Zhang, L., Zheng, P.   +80 more
core   +2 more sources

Double‐Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity‐Stratified Benefits in a Prospective Observational Multicenter Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.
Both Double‐Filtration Plasmapheresis (DFPP) and efgartigimod effectively treat acute exacerbations of generalized myasthenia gravis (gMG), with efficacy rising across successive sessions. In moderate‐to‐severe gMG, 3/5‐session DFPP outperformed 4‐infusion efgartigimod, while efficacy was comparable in mild cases.
Kan Wang, Hanyu Xin, Mengze Zhang, Qiuju Li, Yanan Wu, Xia Li, Jing Peng, Chong Xie, Xiajun Zhou, Li Gao, Xuzhong Pei, Yiwei Yang, Yuhui Wang, Yuan Zhong, Lu Zhang, Desheng Zhu, Yangtai Guan   +16 more
wiley   +1 more source

Primary care for the Roma in Europe : position paper of the European forum for primary care [PDF]

, 2016
Roma populations’ low health status and limited access to health services, including primary care, has been documented in many European countries, and warrants specific health policies and practices.
De Graaf, Pim, Hanssens, Lise, Rotar Pavlič, Danica, Vintges, Marga, Willems, Sara, Zelko, Erika   +5 more
core   +2 more sources

Predictors of Extubation Failure in Myasthenic Crisis [PDF]

Archives of Neurology, 2008
The ideal timing for extubation of patients with myasthenic crisis (MC) and the factors that influence extubation outcome are not well established.To assess the risk of extubation failure in MC and to identify predictors of extubation failure.We reviewed consecutive episodes of MC treated with endotracheal intubation from January 1, 1987, through ...
Janaka, Seneviratne, Jay, Mandrekar, Eelco F M, Wijdicks, Alejandro A, Rabinstein   +3 more
openaire   +2 more sources

Modulation of Cytokines and Immune Cells by Plasma Exchange in Patients With Certain Autoimmune Neurological Diseases

Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.
ABSTRACT Objective Therapeutic plasma exchange (TPE) plays a crucial role in the management of autoimmune neurological disorders, although its effects on cytokines and immune cells are not fully understood. This study aimed to investigate the impact of TPE on immune cell subsets, cytokine levels, and immunoglobulins. Methods A total of 85 patients with
Wanquan Xu, Shuting Chai, Gang Liu, Fei Tian, Weibi Chen, Dawei Shan, Yan Zhang   +6 more
wiley   +1 more source

Efgartigimod for patients with thymoma associated generalized myasthenia gravis during the perioperative period: a four-case report

Frontiers in Immunology
BackgroundThymectomy is one of the main treatments for thymoma associated myasthenia gravis, but there is a risk of acute exacerbation of myasthenia gravis symptoms during the perioperative period of thymoma.
Liuli Ren, Ling Wei, Song Jiang, Hongru Li, Anguo Chen, Juanjuan Zhang   +5 more
doaj   +1 more source

Severe Myasthenic Manifestation of Leptospirosis Associated with New Sequence Type of Leptospira interrogans

Emerging Infectious Diseases, 2019
We report the rapid development of a myasthenic crisis as the first-time manifestation of myasthenia gravis. The symptoms developed in the course of acute leptospirosis associated with a new sequence type of Leptospira interrogans.
Matthias Tomschik, Inga Koneczny, Anna-Margarita Schötta, Sebastian Scharer, Merima Smajlhodzic, Paloma Fernandes Rosenegger, Martin Blüthner, Romana Höftberger, Fritz Zimprich, Gerold Stanek, Mateusz Markowicz   +10 more
doaj   +1 more source

Thymomatous myasthenia gravis [PDF]

, 2010
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disorder targeting skeletal muscle acetylcholine receptor. Thymoma is associated with MG in some patients, the majority of whom present with symptoms of MG before detection of underlying thymoma.
Chan, KH, Cheung, RTF, Chu, ACY, Ho, PWL, Ho, SL, Liu, HHW, Mak, W, Pang, SYY, Tsang, JWH, Tse, MMY   +9 more
core  

Impact of Combined Additional Resections on the Surgical Outcomes of Robot‐Assisted Resection of Thymic Epithelial Tumors

Journal of Surgical Oncology, Volume 133, Issue 3, Page 382-388, March 2026.
ABSTRACT Background and Objectives Robot‐assisted thoracoscopy (RATS) is rapidly emerging as the preferred approach for the resection of thymic epithelial tumors (TET). Current challenges include the role of RATS in locally advanced disease and combined additional resections.
Benedikt Niedermaier, Nabil Khan, Florian Eichhorn, Maria Zehentmeier, Heidrun Grosch, Raffaella Griffo, Alessio Campisi, Antonia Margineanu, Michael Allgäuer, Petros Christopoulos, Michael Thomas, Hauke Winter, Martin E. Eichhorn   +12 more
wiley   +1 more source

Quality of life and life circumstances in German myasthenia gravis patients [PDF]

, 2010
Background Myasthenia gravis (MG) is a chronic neuromuscular disease. Advances in medical therapy have continuously increased the life expectancy of MG patients, without definitively curing the disease.
Sabine Twork, Susanne Wiesmeth, Jörg Klewer, Dieter Pöhlau, Joachim Kugler   +4 more
core   +2 more sources